We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advances in Fragment-Based Drug Discovery

Article   May 21, 2018 | by Laura Elizabeth Mason, Science Writer, Technology Networks

 
Advances in Fragment-Based Drug Discovery

Laura Mason

Science Writer

 
 
 

RELATED ARTICLES

UHPLC- Robust Technology Built to Perform

Article

Chromatography is the backbone of analytical laboratories with high performance liquid chromatography (HPLC) representing the largest portion. Classical HPLC has been challenged - or complemented - in the last decade by ultrahigh performance liquid chromatography (UHPLC).

READ MORE

Epigenetics and Drug Discovery

Article

This article aims to highlight the key types of epigenetic modification, summarize current and emerging drug discovery efforts to target epigenetic dysregulation and will discuss some of the benefits and challenges of epigenetic therapeutics.

READ MORE

Current Trends in Bispecifics, Dual-action and Combination Therapies

Article

It’s becoming increasingly apparent that treatments for complex diseases such as cancer, neurodegenerative diseases and depression are unlikely to target a single molecule in the pathological pathway. Drug developers are turning to new ways to exploit more than one drug target at a time.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE